Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
| ▸ | CDK1 | P06493 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | CSNK1A1 | P48729 | 1/20 | 0.30 |
| ▸ | CLK4 | Q9HAZ1 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9181490 | 0.80 | ALDH1A1 (0.47) | ALDH1A1ALOX15TSHR | |
| SCHEMBL9336420 | 0.79 | MEN1 (0.31) | MEN1GAAKMT2A | |
| SCHEMBL15816938 | 0.79 | MEN1 (0.31) | MEN1GAAKMT2A | |
| SCHEMBL10871601 | 0.74 | MEN1 (0.34) | MEN1GAAKMT2A | |
| SCHEMBL9471045 | 0.72 | ALDH1A1 (0.39) | ALDH1A1ALOX15TSHR | |
| SCHEMBL1182747 | 0.72 | ALDH1A1 (0.39) | ALDH1A1ALOX15TSHRHTTCDK1 | |
| SCHEMBL3569028 | 0.69 | MEN1 (0.37) | MEN1GAAKMT2A | |
| SCHEMBL19754271 | 0.68 | IDO1 (0.41) | ALDH1A1ALOX15TSHRHTTCDK1 | |
| SCHEMBL20267103 | 0.68 | ALDH1A1 (0.35) | ALDH1A1ALOX15TSHRHTTCDK1 | |
| SCHEMBL18562671 | 0.68 | MEN1 (0.34) | MEN1GAAKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10550277-B2 | Ink composition, ink set, and recording method | SEIKO EPSON CORPORATION (JP) | 2020-02-04 | — | — | US | disclosed |
| US-5128455-A | WATER-SOLUBLE FIBER-REACTIVE DYES, CONTAINING AN AMINO-SUBSTITUTED 5-TRIAZINE RING WITH A FIBER-REACTIVE GROUP OF THE VINYLSULFONE SERIES | HOECHST AKTIENGESELLSCHAFT (DE) | 1992-07-07 | — | — | US | disclosed |
| US-4948879-A | Monoazo compounds containing a fiber-reactive group and an oxazolopyridone or oxazinopyridone coupling component | HOECHST AKTIENGESELLSCHAFT (DE) | 1990-08-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10550277-B2 | Ink composition, ink set, and recording method | IK, CD99, MKI67 | ALDH1A1 117/4885ALOX15 3554/4885TSHR 4845/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.